Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis
Status:
Completed
Trial end date:
2015-12-10
Target enrollment:
Participant gender:
Summary
To assess the efficacy and safety of loxoprofen sodium hydrogel patch (LX-P) versus
loxoprofen sodium tablet (LX-T) in patients with active ankylosing spondylitis(AS). The trial
includes 70 patients who are randomly assigned to either the LX-P group (LX-P 100 mg per day)
or LX-T group (LX-T 60 mg t.i.d.) for 4 weeks.